Drug Delivery

Most Elderly People Cannot Use Flu Inhaler Effectively

Published in Virus Weekly, March 27th, 2001

Most elderly people cannot use the inhaler device that delivers the anti-influenza drug zanamivir (Relenza), a new study reports.

Researchers suggest that improvements should be made to the inhaler.

Seventy-three patients aged over 65 years, who were unfamiliar with the use of an inhaler, were recruited from seven wards in a large district general hospital. Patients were randomly allocated the Relenza Diskhaler (Glaxo Wellcome) or an alternative device (Turbohaler). Patients were assessed after 15 minutes of tutoring and again 24 hours later, using a point scoring system of five aspects of inhaler technique ("Randomised controlled study of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Source: Virus Weekly (2001-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry